老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Reviva Pharmaceuticals Holdings, Inc.

0.8669
-0.0057-0.65%
盤後：0.90000.0331+3.82%19:58 EDT
成交量：34.62萬
成交額：30.19萬
市值：4,051.89萬
市盈率：-0.96
高：0.9170
開：0.8818
低：0.8511
收：0.8726
資料載入中...
總覽公司新聞公告
2021/09/20

重要事件披露

8-K - Current report
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/16

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/06/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/25

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/19

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/07

重要事件披露

8-K - Current report
2021/05/07

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/19

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/15

重要事件披露

8-K - Current report
2021/03/24

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
更多